Search
Displaying results 1 - 10 of 13 in total
Tocilizumab
go.drugbank.com/drugs/DB06273
ApprovedInvestigational
Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions. It was first described in the literature in 2003 when Chugai, a subsidiary of Roche began developing IL-6 inhibiting monoclonal antibodies. Tocilizumab was granted FDA approval on ...
Cytokine Release Syndrome caused by CAR-T Cell Therapy
go.drugbank.com/conditions/DBCOND0128354Drugs: TocilizumabActive systemic Juvenile idiopathic arthritis
go.drugbank.com/conditions/DBCOND0023275Drugs: TocilizumabSystemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
go.drugbank.com/conditions/DBCOND0163133Systemic Juvenile Idiopathic Arthritis (SJIA)
go.drugbank.com/conditions/DBCOND0075611Giant Cell Arteritis (GCA)
go.drugbank.com/conditions/DBCOND0115353Moderate to Severe Rheumatoid Arthritis
go.drugbank.com/conditions/DBCOND0065339Moderately to Severely Active Rheumatoid Arthritis
go.drugbank.com/conditions/DBCOND0109811Polyarticular Juvenile Idiopathic Arthritis
go.drugbank.com/conditions/DBCOND0025601